ASP Isotopes (NASDAQ:ASPI) Issues Quarterly Earnings Results

ASP Isotopes (NASDAQ:ASPI) released its earnings results on Wednesday, May 20th. The company reported ($0.22) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.06, Zacks reports. The company had revenue of $8.36 million for the quarter, compared to analysts’ expectations of $3.68 million. ASP Isotopes had a negative return on equity of 112.46% and a negative net margin of 644.40%.

ASP Isotopes Price Performance

Shares of NASDAQ:ASPI opened at $6.35 on Friday. The firm has a market capitalization of $799.47 million, a price-to-earnings ratio of -3.05 and a beta of 3.42. The company has a debt-to-equity ratio of 0.69, a current ratio of 4.39 and a quick ratio of 4.37. The business’s 50 day simple moving average is $6.17 and its 200-day simple moving average is $5.90. ASP Isotopes has a 12 month low of $3.92 and a 12 month high of $14.49.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on ASPI shares. Weiss Ratings restated a “sell (d-)” rating on shares of ASP Isotopes in a research note on Wednesday. Canaccord Genuity Group reiterated a “buy” rating and issued a $11.00 price objective on shares of ASP Isotopes in a research report on Tuesday, April 14th. Two equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $13.00.

Insider Transactions at ASP Isotopes

In other ASP Isotopes news, Director Duncan Moore sold 11,642 shares of the company’s stock in a transaction on Thursday, April 16th. The stock was sold at an average price of $5.21, for a total value of $60,654.82. Following the sale, the director owned 1,044,928 shares of the company’s stock, valued at approximately $5,444,074.88. This represents a 1.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Paul Elliot Mann sold 83,759 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The shares were sold at an average price of $7.76, for a total value of $649,969.84. Following the completion of the transaction, the chief executive officer owned 9,579,845 shares of the company’s stock, valued at approximately $74,339,597.20. This represents a 0.87% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last quarter, insiders sold 233,221 shares of company stock valued at $1,707,989. Company insiders own 14.40% of the company’s stock.

Institutional Investors Weigh In On ASP Isotopes

A number of large investors have recently added to or reduced their stakes in ASPI. Integrated Wealth Concepts LLC acquired a new position in shares of ASP Isotopes in the fourth quarter valued at approximately $99,000. Tocqueville Asset Management L.P. acquired a new stake in ASP Isotopes during the fourth quarter worth about $91,000. J.W. Cole Advisors Inc. acquired a new stake in ASP Isotopes during the 4th quarter worth approximately $85,000. Legal & General Group Plc raised its stake in shares of ASP Isotopes by 30.4% in the 3rd quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock valued at $81,000 after acquiring an additional 1,953 shares during the period. Finally, B. Riley Wealth Advisors Inc. purchased a new position in ASP Isotopes in the second quarter valued at about $121,000. 16.80% of the stock is owned by institutional investors and hedge funds.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.